Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy

Launched by BRIGHAM AND WOMEN'S HOSPITAL · Mar 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new computer-based tool designed to help doctors and patients with Peripheral Artery Disease (PAD) make better decisions about cholesterol-lowering medications. The goal is to see if using alerts from this tool can encourage more patients with PAD, who are not currently taking cholesterol-lowering drugs, to start treatment with statins or similar medications. This is important because managing cholesterol can help improve heart health and reduce the risk of complications associated with PAD.

To participate in this trial, you need to be at least 18 years old and have been diagnosed with PAD. You must not be currently taking any cholesterol-lowering medications. If you join the study, you’ll be one of 400 patients and will receive care at various clinics, including those for cardiovascular health and diabetes. Throughout the trial, you can expect regular check-ups and support from healthcare professionals as they evaluate how well the alert system works in helping patients start necessary treatment for their condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients ≥ 18 years old
• • Seen in Cardiovascular Medicine Clinic, Primary Care, Podiatry, Vascular Surgery, and Diabetology
• • Medical history entry, visit diagnosis, or problem list entry of PAD
• • Not prescribed LDL-C-lowering therapy
• Exclusion Criteria:
• • Patients taking a statin, ezetimibe, bempedoic acid, a PCSK9 inhibitor, inclisiran or a combination will be excluded